webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Cbz-Phe-(Alloc)Lys-PAB-PNP

  CAS No.: 159857-90-6   Cat No.: BADC-00491   Purity: ≥98% 4.5  

Cbz-Phe-(Alloc)Lys-PAB-PNP is an important biomedical chemical product that has emerged as a potential therapeutic agent against various diseases. It has demonstrated outstanding capabilities as a candidate compound for targeted therapy against various malignancies, including breast and prostate cancer. This revolutionary compound, Cbz-Phe-(Alloc)Lys-PAB-PNP, utilizes its unique molecular structure to produce profound inhibitory effects on the proliferation of malignant cells.

Cbz-Phe-(Alloc)Lys-PAB-PNP

Structure of 159857-90-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C41H43N5O11
Molecular Weight
781.81
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
[4-[[(2S)-1-amino-1-oxo-6-(prop-2-enoxycarbonylamino)hexan-2-yl]-[(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate;
IUPAC Name
[4-[[(2S)-1-amino-1-oxo-6-(prop-2-enoxycarbonylamino)hexan-2-yl]-[(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
Canonical SMILES
C=CCOC(=O)NCCCCC(C(=O)N)N(C1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])C(=O)C(CC3=CC=CC=C3)NC(=O)OCC4=CC=CC=C4
InChI
InChI=1S/C41H43N5O11/c1-2-25-54-39(49)43-24-10-9-15-36(37(42)47)45(32-18-16-31(17-19-32)28-56-41(51)57-34-22-20-33(21-23-34)46(52)53)38(48)35(26-29-11-5-3-6-12-29)44-40(50)55-27-30-13-7-4-8-14-30/h2-8,11-14,16-23,35-36H,1,9-10,15,24-28H2,(H2,42,47)(H,43,49)(H,44,50)/t35-,36-/m0/s1
InChIKey
ZDMMWLUQPVUZQI-ZPGRZCPFSA-N
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.

Cbz-Phe-(Alloc)Lys-PAB-PNP, a synthetic compound essential in peptide synthesis and biochemical research, finds diverse applications.

Peptide Synthesis: Serving as a foundational element in crafting intricate peptides, Cbz-Phe-(Alloc)Lys-PAB-PNP plays a pivotal role in peptide assembly. Its distinct protective groups enable selective deprotection and coupling reactions, ensuring the precise construction of peptide chains. This precision is critical for generating ultra-pure peptides for both research endeavors and therapeutic interventions.

Drug Development: Within the realm of pharmaceutical innovation, Cbz-Phe-(Alloc)Lys-PAB-PNP emerges as a potent tool for engineering peptide-based drugs. By integrating this compound into peptide synthesis protocols, scientists can fabricate and evaluate novel therapeutic peptides characterized by exceptional specificity and potency. This application holds particular significance in the quest for treatments targeting diseases where peptide-based therapies exhibit significant potential.

Bioconjugation: Instrumental in the realm of bioconjugation methodologies, Cbz-Phe-(Alloc)Lys-PAB-PNP facilitates the linking of peptides to various molecules for multifaceted applications. This compound enables the modification of peptides with diverse functional groups, such as fluorophores and enzymes.

Proteomics Research: In the domain of proteomics, Cbz-Phe-(Alloc)Lys-PAB-PNP is harnessed to delve into protein interactions and functionalities. By synthesizing tagged peptides utilizing this compound, researchers can explore protein binding sites and unravel intricate protein-protein interactions. This exploration aids in deciphering cellular processes and identifying potential targets for drug development, paving the way for groundbreaking discoveries in the realm of proteomics.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Azido-PEG7-amine | Gly-NH-CH2-Boc | Py-MAA-Val-Cit-PAB-MMAE | Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 | (2R,10S)-10-Benzyl-2-cyclopropyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosanoic acid | Mal-di-PEG-Val-Cit-PAB | N3-PEG3-VC-PAB-MMAE | Mal-PEG6-NHS | Boc-Phe-(Alloc)Lys-PAB-PNP | MPB-VC-PAB-DM1 | Cbz-Phe-(Alloc)Lys-PAB-PNP
Send Inquiry
Verification code
Inquiry Basket